Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Liabilities and Shareholders Equity: 2010-2024

Historic Liabilities and Shareholders Equity for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to $64.7 million.

  • Cryo Cell International's Liabilities and Shareholders Equity rose 37.29% to $63.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was $256.7 million, marking a year-over-year increase of 189.62%. This contributed to the annual value of $64.7 million for FY2024, which is 0.0% changed from last year.
  • Cryo Cell International's Liabilities and Shareholders Equity amounted to $64.7 million in FY2024, which was down 0.0% from $64.7 million recorded in FY2023.
  • In the past 5 years, Cryo Cell International's Liabilities and Shareholders Equity registered a high of $64.9 million during FY2022, and its lowest value of $46.2 million during FY2020.
  • In the last 5 years, Cryo Cell International's Liabilities and Shareholders Equity had a median value of $64.7 million in 2023 and averaged $60.2 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 3130.29% in 2021, then plummeted by 32.43% in 2023.
  • Cryo Cell International's Liabilities and Shareholders Equity (Annual) stood at $46.2 million in 2020, then surged by 31.3% to $60.7 million in 2021, then rose by 6.97% to $64.9 million in 2022, then dropped by 0.32% to $64.7 million in 2023, then changed by 0.0% to $64.7 million in 2024.
  • Its Liabilities and Shareholders Equity stands at $64.7 million for FY2024, versus $64.7 million for FY2023 and $64.9 million for FY2022.